Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865679 · ClinicalTrials.gov registry record · NA
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
A NA study of Amputation and Symptomatic Neuroma, sponsored by Axogen Corporation.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT04865679 is a NA study of Amputation and Symptomatic Neuroma that is active but no longer recruiting, run by Axogen Corporation. The registered enrollment target is 15 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04865679, a NA study of Amputation and Symptomatic Neuroma, is active but no longer recruiting, sponsored by Axogen Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot study evaluates the tolerability and feasibility of the Axoguard Large-Diameter Nerve Cap (sizes 5-7 mm) for protecting and preserving terminated nerve endings after limb trauma or amputation when immediate attention to the nerve injuries is not possible.
Conditions Studied
Interventions
- DEVICE Axoguard Nerve Cap®
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Texas
- Texas Tech University, Health Science Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04865679
The ClinicalTrials.gov registry entry for NCT04865679 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (89% lower). The listed sponsor is Axogen Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Axoguard Nerve Cap® is the first listed.
NCT04865679 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT04865679 about?
NCT04865679 is a clinical study titled "Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends". This pilot study evaluates the tolerability and feasibility of the Axoguard Large-Diameter Nerve Cap (sizes 5-7 mm) for protecting and preserving terminated nerve endings after limb trauma or amputation when immediate attention to the nerve injuries is not possible.
What is the current status of trial NCT04865679?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-03-02. Estimated completion is 2026-12.
What conditions does trial NCT04865679 study?
This clinical trial studies the following conditions: Amputation, Symptomatic Neuroma, Chronic Nerve Pain.
What interventions are being tested in trial NCT04865679?
The interventions under investigation include: Axoguard Nerve Cap® (DEVICE).
Who is sponsoring clinical trial NCT04865679?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04865679 being conducted?
This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.